EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Intermittent Fasting as a Potential Therapeutic Instrument for Major Depression Disorder: A Systematic Review of Clinical and Preclinical Studies

Laís Murta iD, Daniela Seixas, Luana Harada, Rodolfo Furlan Damiano iD, Marcus Zanetti

International Journal of Molecular Sciences · 25.10.2023 · 24 (21) · 15551

DOI: 10.3390/ijms242115551 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.10.2023. Verfasst von Laís Murta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Sírio-Libanês, Sao Paulo 01308-050, Brazil. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have reported positive effects of Intermittent Fasting (IF) on metabolic parameters, cognition, and mood. However, regarding depressive symptoms, the effect of IF is not clear. The purpose of this review was to assess the available evidence on IF interventions for depression in both clinical and preclinical studies. Of the 23 included studies, 15 were performed on humans and 8 on animal models. The studies on rodents suggested that IF acts as a circadian regulator, improving neurotransmitter availability and increasing the levels of neurotrophic factors in the brain. However, the investigations on humans mainly evaluated healthy volunteers and showed a great heterogeneity regarding both the IF regimen studied and the observed effects on mood. Most available clinical trials have specific limitations, such as small sample sizes and uncontrolled designs. A comprehensive systematic review was conducted on five databases, PubMed, Cochrane, the Central Register of Controlled Trials, Web of Science databases, BVS and Scopus, identifying 23 relevant studies up to 6 October 2022. IF has potentially relevant physiological effects for the treatment of mood disorders, but better designed studies and controlled evaluations are needed to evaluate its efficiency in the treatment of major depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderHumansDepressionIntermittent FastingMood DisordersBrain

Stichwörter der Autor:innen

depressiondisorderintermittent fastingmajor depressivemajor depressive disordermoodmood disorderrestricted feeding

Autor:innen und Institutionen

  • Hospital Sírio-Libanês, Sao Paulo 01308-050, Brazil.
  • Faculdade de Medicina, Universidade de São Paulo, Sao Paulo 01246-903, Brazil.

ORCID-Profile: Laís Murta, Rodolfo Furlan Damiano

Zitieren

APA

Murta, L., Seixas, D., Harada, L., Damiano, R. F., & Zanetti, M. (2023). Intermittent Fasting as a Potential Therapeutic Instrument for Major Depression Disorder: A Systematic Review of Clinical and Preclinical Studies. International Journal of Molecular Sciences, 24(21), 15551. https://doi.org/10.3390/ijms242115551

Vancouver

Murta L, Seixas D, Harada L, Damiano RF, Zanetti M. Intermittent Fasting as a Potential Therapeutic Instrument for Major Depression Disorder: A Systematic Review of Clinical and Preclinical Studies. International Journal of Molecular Sciences. 2023;24(21):15551. doi:10.3390/ijms242115551

BibTeX
@article{Murta2023,
  author = {Murta, Laís and Seixas, Daniela and Harada, Luana and Damiano, Rodolfo Furlan and Zanetti, Marcus},
  title = {Intermittent Fasting as a Potential Therapeutic Instrument for Major Depression Disorder: A Systematic Review of Clinical and Preclinical Studies},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {21},
  pages = {15551},
  doi = {10.3390/ijms242115551}
}
Kostenlos starten →